

An edition of RU-486, status report on the U.S. commercialization project, transfer of antiprogestin technology to the United States (1994)
hearing before the Subcommittee on Regulation, Business Opportunities, and Technology of the Committee on Small Business, House of Representatives, One Hundred Third Congress, second session, Washington, DC, May 16, 1994.
By United States. Congress. House. Committee on Small Business. Subcommittee on Regulation, Business Opportunities, and Technology.
Publish Date
1994
Publisher
U.S. G.P.O.,For sale by the U.S. G.P.O., Supt. of Docs., Congressional Sales Office
Language
-
Pages
48
Description:
subjects: Government policy, Mifepristone, Antagonists, Pharmaceutical policy, Progesterone
Places: United States